Current Appointments & Affiliations
Adjunct Professor in the Department of Dermatology
·
2021 - Present
Dermatology,
Clinical Science Departments
Recent Publications
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis.
Journal Article J Dermatolog Treat · December 2025 BACKGROUND: Lebrikizumab monotherapy significantly improved signs and symptoms in patients with moderate-to-severe atopic dermatitis (AD) in phase 3 Advocate1 and ADvocate2 studies. OBJECTIVE: To evaluate improvements in patient-reported symptoms and quali ... Full text Link to item CiteThe efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials.
Journal Article J Am Acad Dermatol · May 2025 BACKGROUND: Lebrikizumab demonstrated statistically significant improvements in patients with moderate-to-severe atopic dermatitis at week 16 with a durable response up to week 52. OBJECTIVE: To investigate the efficacy of lebrikizumab-treated patients at ... Full text Link to item CiteNorth American Contact Dermatitis Group Patch Test Results: 2021-2022.
Journal Article Dermatitis · April 24, 2025 Background: Patch testing is an important diagnostic tool for the assessment of allergic contact dermatitis (ACD). Objective: This study documents the North American Contact Dermatitis Group (NACDG) patch testing results from 2021 to 2022. Methods: At 12 c ... Full text Link to item CiteEducation, Training & Certifications
University of Illinois ·
2002
M.D.
University of Illinois, Urbana-Champaign ·
1998
B.S.